{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:06:41Z","timestamp":1772752001959,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1067\/mjd.2001.117852","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"871-881","source":"Crossref","is-referenced-by-count":56,"title":["A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB389IL-2) in patients with severe psoriasis"],"prefix":"10.1067","volume":"45","author":[{"given":"Ann","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie","family":"Muglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Pappert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.Thomas","family":"Garland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Bagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Bacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2001.117852_bib1","first-page":"1","article-title":"An overview of psoriasis","author":"Weinstein","year":"1993"},{"key":"10.1067\/mjd.2001.117852_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2133.1987.tb05869.x","article-title":"The effects of cyclosporin A on T lymphocytes and dendritic cell sub-populations in psoriasis","volume":"116","author":"Baker","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.117852_bib3","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(89)92941-3","article-title":"Use of cyclosporin in psoriasis","volume":"2","author":"Bos","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.117852_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1996.03890280081011","article-title":"Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study","volume":"132","author":"The European FK506 Multicentre Psoriasis Study Group","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.117852_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0560.1996.tb01430.x","article-title":"Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes","volume":"23","author":"Gottlieb","year":"1996","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2001.117852_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90464-Z","article-title":"Chimaeric CD4 monoclonal antibody in treatment of generalized pustular psoriasis","volume":"338","author":"Prinz","year":"1991","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.117852_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.180.1.283","article-title":"PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy","volume":"180","author":"Vallat","year":"1994","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2001.117852_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1067\/mjd.2001.117852_bib9","first-page":"11885","article-title":"Structure\/function analysis of interleukin-2-toxin (DAB486IL-2): fragment B sequences required for the delivery of fragment A to the cytosol of target cells","volume":"265","author":"Williams","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1067\/mjd.2001.117852_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/eji.1830200412","article-title":"Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells","volume":"20","author":"Waters","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1067\/mjd.2001.117852_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","article-title":"Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T cell lymphoma","volume":"19","author":"Olsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2001.117852_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0190-9622(98)70403-7","article-title":"Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides","volume":"39","author":"Saleh","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.117852_bib13","first-page":"399","article-title":"Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2","volume":"91","author":"LeMaistre","year":"1998","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.117852_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1096-8652(199805)58:1<87::AID-AJH18>3.0.CO;2-2","article-title":"DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma","volume":"58","author":"Duvic","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1067\/mjd.2001.117852_bib15","first-page":"48","article-title":"Use of interleukin-2 fusion protein, DAB389IL-2, for the treatment of psoriasis","volume":"5","author":"Gottlieb","year":"1998","journal-title":"Dermatol Ther"},{"key":"10.1067\/mjd.2001.117852_bib16","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(98)70590-0","article-title":"Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial","volume":"38","author":"Bagel","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.117852_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis: oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220107623X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220107623X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T09:30:30Z","timestamp":1557394230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220107623X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S019096220107623X"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2001.117852","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}